featured
Treat and Extend Regimen With Ranibizumab for Neovascular Age-Related Macular Degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Changing From a Pro Re Nata Treatment Regimen to a Treat and Extend Regimen With Ranibizumab in Neovascular Age-Related Macular Degeneration
Br J Ophthalmol 2016 Jan 11;[EPub Ahead of Print], K Hatz, C PrünteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.